TABLE 1. Reported cases and rates of gonorrhea and proportion of isolates available for antimicrobial susceptibility tests, by province — 13 Gonococcal Resistance Surveillance Program sentinel sites,* China, 2022.
| Province | Population | No. of reported gonorrhea cases | Rate† | No. of isolates tested for antimicrobial susceptibility (%) |
|---|---|---|---|---|
| Chongqing |
32,119,942 |
2,498 |
7.78 |
66 (2.6) |
| Guangdong |
126,840,013 |
22,171 |
17.48 |
751 (3.4) |
| Guangxi |
50,369,886 |
6,162 |
12.23 |
719 (11.7) |
| Hainan |
10,199,964 |
1,466 |
14.37 |
57 (3.9) |
| Hunan |
66,220,222 |
3,016 |
4.55 |
66 (2.2) |
| Jiangsu |
85,050,277 |
5,354 |
6.30 |
248 (4.6) |
| Shanghai |
24,889,864 |
1,339 |
5.38 |
111 (8.3) |
| Shanxi |
39,539,596 |
1,405 |
3.55 |
65 (4.6) |
| Sichuan |
83,721,532 |
3,235 |
3.86 |
120 (3.7) |
| Tianjin |
13,730,084 |
293 |
2.13 |
53 (18.1) |
| Xinjiang |
25,889,690 |
905 |
3.50 |
27 (3.0) |
| Yunnan |
46,899,911 |
6,913 |
14.74 |
146 (2.1) |
| Zhejiang | 65,400,126 | 13,460 | 20.58 | 375 (2.8) |
* Data from 13 of 19 provincial sentinel surveillance sites were included in the analysis; only 2,804 isolates were tested for antimicrobial susceptibility, accounting for 4.1% of all reported cases in the 13 participating provinces.
† Per 100,000 population.